Author: | Spriggs, D. |
Article Title: | Gynecologic oncology: Introduction |
Keywords: | cancer survival; treatment outcome; cancer surgery; survival rate; clinical trial; cancer recurrence; salvage therapy; cisplatin; doxorubicin; advanced cancer; cancer combination chemotherapy; cancer growth; drug efficacy; side effect; treatment planning; united states; conference paper; gemcitabine; paclitaxel; cancer radiotherapy; topotecan; antineoplastic agent; endometrium cancer; cancer palliative therapy; carboplatin; quality of life; ovary cancer; bone marrow suppression; etoposide; blood toxicity; lung cancer; antineoplastic activity; cancer mortality; cancer resistance; irinotecan; europe; lung small cell cancer; symptom; kidney function; uterine cervix cancer; drug response; platinum; taxane derivative; cancer control; dna topoisomerase inhibitor; gynecologic cancer; cross resistance; drug indication; prognosis; human; priority journal |
Journal Title: | Gynecologic Oncology |
Volume: | 90 |
Issue: | 3 Suppl. |
ISSN: | 0090-8258 |
Publisher: | Elsevier Inc. |
Date Published: | 2003-09-01 |
Start Page: | S1 |
End Page: | S2 |
Language: | English |
DOI: | 10.1016/s0090-8258(03)00469-4 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Export Date: 25 September 2014 -- Source: Scopus |